Log on / register
Feedback | Support | My details
Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy.
Pendleton JM, Tan WW, Anai S, Chang M, Hou W, Shiverick KT, Rosser CJ
BMC Cancer 2008, 8:132
[Full text] [PubMed] [Related articles]


No citations for this article were found in PubMed Central.


You can also check ISI Web of Science for additional citations (subscription required)
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated